Skip to main content

Table 2 Neoadjuvant chemotherapy treatment regimens and evaluation of their effectiveness

From: Uniportal video-assisted thoracoscopic surgery following neoadjuvant chemotherapy for locally-advanced lung cancer

Neoadjuvant treatment regimen Effectiveness, n (%)
CR PR SD
GP 12 4
DP 5 3
EC 5
  1. GP (gemcitabine + cisplatin): gemcitabine 1000 mg/m2, intravenous infusion, d1, d8; total cisplatin 90 mg/m2, intravenous infusion, d2–5, 21 days as one cycle; DP (docetaxel + cisplatin), docetaxel injection, intravenous infusion, 75 mg/m2, d1, total cisplatin 90 mg/m2, intravenous infusion, d2–5, 21 days as one cycle; EC (Etoposide,VP-16 + carboplatin), carboplatin intravenous infusion, d1, AUC (area under the curve) method to calculate the carboplatin dose, AUC = 5.5, total etoposide 100 mg/m2,d2–6, 21 days as one cycle